|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/00 | |||
| A61K 9/70 | |||
| A61K 31/133 | |||
| A61K 31/137 |
| (11) | Patento numeris | 2952177 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15173766.5 |
| Europos patento paraiškos padavimo data | 2008-10-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 979482 P | 2007-10-12 | US |
| (72) |
RUEGGER, Colleen, CH
AMBUEHL, Michael, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMPOSITIONS COMPRISING SPHINGOSINE 1 PHOSPHATE (S1P) RECEPTOR MODULATORS |
| COMPOSITIONS COMPRISING SPHINGOSINE 1 PHOSPHATE (S1P) RECEPTOR MODULATORS |